ManaT Bio Funding: $150M Raised, Series A (2024)

ManaT Bio is based in Baltimore. It has raised $150M in total funding. Latest round: Series A. Backed by Third Rock Ventures, Novo Holdings, Catalio Capital.

ManaT Bio funding overview

ManaT Bio is based in Baltimore. ManaT Bio has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2024. The round record for ManaT Bio runs through 2024; nothing later has been disclosed. Investors on record include Third Rock Ventures, Novo Holdings, Catalio Capital. 3 distinct backers are named across the disclosed rounds.

ManaT Bio at a glance

Total raised
$150M
Latest round
Series A
Latest round date
March 2024
Headquarters
Baltimore
Notable investors
Third Rock Ventures, Novo Holdings, Catalio Capital

Frequently asked about ManaT Bio funding

How much has ManaT Bio raised?
ManaT Bio has raised $150M in total disclosed funding across the rounds on record.
Who has invested in ManaT Bio?
Third Rock Ventures, Novo Holdings, Catalio Capital are named among the investors backing ManaT Bio.
What was the latest ManaT Bio funding round?
The most recent disclosed round is a Series A, announced in March 2024.
Where is ManaT Bio based?
ManaT Bio is based in Baltimore.
When did ManaT Bio last raise?
The last disclosed ManaT Bio round closed in March 2024 at Series A.

Totals shown for ManaT Bio aggregate every disclosed round on file. To see how that compares, browse the companies in Baltimore and the investors behind them below.

Companies related to ManaT Bio (36)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026